Cargando…
Development of a drug–device combination for fluorescence-guided surgery in neuroendocrine tumors
Significance: The use of cancer-targeted contrast agents in fluorescence-guided surgery (FGS) has the potential to improve intraoperative visualization of tumors and surgical margins. However, evaluation of their translational potential is challenging. Aim: We examined the utility of a somatostatin...
Autores principales: | Hernandez Vargas, Servando, Lin, Christie, Voss, Julie, Ghosh, Sukhen C., Halperin, Daniel M., AghaAmiri, Solmaz, Cao, Hop S. Tran, Ikoma, Naruhiko, Uselmann, Adam J., Azhdarinia, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Photo-Optical Instrumentation Engineers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725236/ https://www.ncbi.nlm.nih.gov/pubmed/33300316 http://dx.doi.org/10.1117/1.JBO.25.12.126002 |
Ejemplares similares
-
Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents
por: Hernandez Vargas, Servando, et al.
Publicado: (2021) -
Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer
por: AghaAmiri, Solmaz, et al.
Publicado: (2021) -
Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications
por: Usama, Syed Muhammad, et al.
Publicado: (2022) -
High-Contrast
Detection of Somatostatin Receptor Subtype-2
for Fluorescence-Guided Surgery
por: Hernandez Vargas, Servando, et al.
Publicado: (2022) -
Combined multiphoton microscopy and somatostatin receptor type 2 imaging of pancreatic neuroendocrine tumors
por: Daigle, Noelle, et al.
Publicado: (2023)